Immortalization of primary human prostate epithelial cells by c-Myc

被引:96
作者
Gil, J
Kerai, P
Lleonart, M
Bernard, D
Cigudosa, JC
Peters, G
Carnero, A
Beach, D
机构
[1] London Res Inst, Canc Res UK, Oncol Mol Lab, London WC2A 3PX, England
[2] Inst Cell & Mol Sci, Ctr Cutaneous Biol, London, England
[3] Univ Cambridge, Canc Res UK, Dept Oncol, Cambridge CB2 1TN, England
[4] Hutchinson MRC, Res Ctr, MRC Canc Cell Unit, Cambridge, England
[5] Univ Autonoma Barcelona, Hosp Gen Valle Hebron, Dept Pathol, E-08193 Barcelona, Spain
[6] Univ Libre Brussels, Fac Med, Mol Virol Lab, B-1050 Brussels, Belgium
[7] Ctr Nacl Invest Oncol, Cytogenet Unit, Biotechnol Program, Madrid, Spain
[8] Ctr Nacl Invest Oncol, Expt Therapeut Program, Madrid, Spain
关键词
D O I
10.1158/0008-5472.CAN-03-4030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A significant percentage of prostate tumors have amplifications of the c-Myc gene, but the precise role of c-Myc in prostate cancer is not fully understood. Immortalization of human epithelial cells involves both inactivation of the Rb/ P16(INK4a) pathway and telomere maintenance, and it has been recapitulated in culture by expression of the catalytic subunit of telomerase, hTERT, in combination with viral oncoproteins. Here, we show the immortalization of human prostate epithelial cells (HPrEC) by a single genetic event, the expression of the c-Myc oncogene. Myc stabilizes telomere length in HPrEC through up-regulation of hTERT expression and overrides the accumulation of cell cycle inhibitory proteins, such as p16(INK4a). Overall, HPrECs expressing c-Myc retain many characteristics of normal cells, such as the induction of a senescence-like growth arrest in response to oncogenic Ras, an intact p53 response, and an absence of gross karyotypic abnormalities. However, HPrECs expressing c-Myc lack a Rb/p16(INK4a) checkpoint and can be transformed without the need for additional genetic lesions in that pathway. These results give a partial explanation for the physiologic role of c-Myc overexpression in prostate cancer.
引用
收藏
页码:2179 / 2185
页数:7
相关论文
共 60 条
[1]   Molecular genetics of prostate cancer [J].
Abate-Shen, C ;
Shen, MM .
GENES & DEVELOPMENT, 2000, 14 (19) :2410-2434
[2]   Cyclin E and c-Myc promote cell proliferation in the presence of p16(INK4a) and of hypophosphorylated retinoblastoma family proteins [J].
Alevizopoulos, K ;
Vlach, J ;
Hennecke, S ;
Amati, B .
EMBO JOURNAL, 1997, 16 (17) :5322-5333
[3]   Normal human fibroblasts are resistant to RAS-induced senescence [J].
Benanti, JA ;
Galloway, DA .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2842-2852
[4]  
Bernard D, 2003, J CLIN INVEST, V112, P1724
[5]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[6]   Control of cell proliferation by Myc [J].
Bouchard, C ;
Staller, P ;
Eilers, M .
TRENDS IN CELL BIOLOGY, 1998, 8 (05) :202-206
[7]   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[8]   Identification of specific PP2A complexes involved in human cell transformation [J].
Chen, W ;
Possemato, R ;
Campbell, KT ;
Plattner, CA ;
Pallas, DC ;
Hahn, WC .
CANCER CELL, 2004, 5 (02) :127-136
[9]  
Cheville JC, 1998, MODERN PATHOL, V11, P324
[10]   Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma [J].
Cote, RJ ;
Shi, Y ;
Groshen, S ;
Feng, AC ;
Cordon-Cardo, C ;
Skinner, D ;
Lieskovosky, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12) :916-920